HOME >> BIOLOGY >> NEWS
NIAID awards grant to rapidly sequence the malaria mosquito genome

The National Institute of Allergy and Infectious Diseases (NIAID) today announced a $9 million award to help reveal the genetic secrets of malaria, a complex disease responsible for up to 3 million deaths worldwide each year. Through the grant to Celera Genomics Group, NIAID has expanded its efforts to determine the genetic blueprint of Anopheles gambiae, a mosquito species that transmits the malaria parasite to people. As part of an international consortium of A. gambiae researchers and genome sequencing centers, Celera scientists will help sequence the mosquito genome and make the information freely available to the scientific community. Celera anticipates completing the project next spring.

Malaria is caused by parasites of the genus Plasmodium. The disease strikes 300 to 500 million people annually, 90 percent of who live in sub-Saharan Africa. More than 40 percent of the world's population lives in areas where malaria naturally occurs.

Malaria parasites undergo a complex life cycle; to thrive and spread they must spend parts of their lives in both humans and mosquitoes. To learn more about how the parasite, mosquitoes and humans interact, researchers will study the Anopheles genome along with the recently deciphered human genome and the soon-to-be-completed DNA sequence of the deadliest malaria parasite, Plasmodium falciparum. The three genome sequences will provide scientists with a unique opportunity to study the natural history of malaria. For the first time, researchers will have the complete genetic information on an infectious organism, its natural host, and the insect that transmits the disease from person to person.

"This initiative will give us the pieces to an incredibly complex puzzle," says NIAID Director Anthony S. Fauci, M.D. "By analyzing and comparing the genomes of all three organisms, researchers will have a wealth of new information for understanding malaria and how it is spread, and for use in developing
'"/>

Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
8-Aug-2001


Page: 1 2

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID unveils bioterrorism research agenda
3. NIAID takes next genome step
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Chemical engineering grad students will take notable national awards
9. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
10. NSF awards 22 new projects for plant genome research
11. The American Phytopathological Society announces 2004 awards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the ... today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both ... physician and clinical trial team. , Using the CONSULT module, patients and physicians can ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
Cached News: